e-learning
resources
Milan 2017
Tuesday, 12.09.2017
What is new in COPD diagnosis and classification?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association between third-space fluid and FEV1 in COPD patients
A. Jimenez Cepeda (saltillo, Mexico)
Source:
International Congress 2017 – What is new in COPD diagnosis and classification?
Session:
What is new in COPD diagnosis and classification?
Session type:
Thematic Poster
Number:
3627
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Jimenez Cepeda (saltillo, Mexico). Association between third-space fluid and FEV1 in COPD patients. 3627
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Definition and history of sarcoidosis
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Closing volume predicts the FEV1 response to bronchodilators in patients with COPD
Source: Virtual Congress 2020 – Advances in lung function testing
Year: 2020
Association between weight loss and decline in FVC in patients with IPF
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
Improvement in FEV1 after acute COPD exacerbations are driven more by changes in hyperinflation than changes in proximal airway volume
Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease
Year: 2015
The effect of positive expiratory pressure for airway clearance on ventilation inhomogeneity in individuals with stable COPD and chronic sputum expectoration
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in COPD
Year: 2013
Changes in FEV1 and SpO2 in patients with severe and very severe COPD
Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases
Year: 2021
Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and COPD subjects
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Relationship between FEV1 and PEF in patients with airways obstruction
Source: Eur Respir J 2004; 24: Suppl. 48, 120s
Year: 2004
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
Usefulness of FEV1/SVC to uncover airflow obstruction in subjects with preserved FEV1/FVC
Source: International Congress 2016 – Lung function and imaging: new findings and new approaches
Year: 2016
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV
1
) in patients with severe chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008
Association between nasal and bronchial resistance in patients with COPD
Source: International Congress 2018 – Innovations in equipment and their application
Year: 2018
Changes in FEV1 after recovery from COPD exacerbation are driven by heterogeneous regional changes in airway caliber and hyperinflation
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015
FEV6 or FVC to detect airway obstruction in the community setting?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007
Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV
1
and FEV
1
in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 290s
Year: 2005
FEV
6
as an alternative for FVC in detecting airflow obstruction in COPD patients undergoing six minute Walk test
Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity
Year: 2013
Primary care spirometry
Source: Eur Respir J 2008; 31: 197-203
Year: 2008
Changes of TNF-a level in bronchoalveolar fluid of patients with chronic obstructive pulmonary disease before and after the 30 days treatment with tiotropium bromide
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Changes in spirometry (FVC and FEV
1
) in a closed population of COPD patients using new standarized values for Mexican people
Source: Eur Respir J 2003; 22: Suppl. 45, 69s
Year: 2003
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept